News - Pharmaceutical, Merck Serono

Filter

Popular Filters

1 to 25 of 53 results

Merck KGaA plans to invest 50 million euros in Italian production site

21-05-2014

German pharma and chemicals group Merck KGaA says it plans to invest 50 million euros ($68.5 million)…

FinancialItalyMerck KGaAMerck SeronoPharmaceuticalProduction

Merck Serono in deal with Auxogyn to advance fertility research

03-04-2014

USA-based Auxogyn, a company dedicated to advancing women’s reproductive health, has entered into an…

AuxogynLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

Merck Serono appoints Meeta Gulyani as head of Strategy and Global Franchises

Merck Serono appoints Meeta Gulyani as head of Strategy and Global Franchises

19-03-2014

Merck Seron has announced the appointment of Meeta Gulyani to the position of Head of Strategy and Global…

GermanyMerck SeronoNorthern EuropePharmaceuticalUSA

Germany’s Merck benefits from efficiency measures, with 2013 EBITDA up 9.7%

Germany’s Merck benefits from efficiency measures, with 2013 EBITDA up 9.7%

06-03-2014

German pharma and chemical major Merck KGaA this morning announced strong fourth-quarter and full-year…

FinancialMerck KGaAMerck SeronoPharmaceutical

Product launches to fuel lupus market growth

28-02-2014

The systemic lupus erythematosus (SLE) treatment market in the seven major countries (7MM) will increase…

Anti-Arthritics/RheumaticsBenlystaBristol-Myers SquibbEli LillyepratuzumabGlaxoSmithKlineGlobalImmuPharmaLupuzorMerck SeronoOrenciaPharmaceuticalRituxanRochetabalumabUCB

Merck Serono’s Erbitux to be funded by CDF in England for mCRC

28-02-2014

The UK’s Cancer Drugs Fund (CDF) says that Erbitux (cetuximab) can be used in the first line setting…

ErbituxFinancialHealthcareMerck KGaAMerck SeronoNorthern EuropeOncologyPharmaceuticalUK

moksha8 files Viibryd and Colobreathe in Brazil; amends Forest alliance

06-01-2014

Brazil-based pharma firm moksha8 has filed applications with the Brazilian regulatory authority, ANVISA,…

BrazilColoBreatheForest LaboratoriesLicensingMerck SeronoMoksha8NeurologicalPharmaceuticalRare diseasesRegulationSouth AmericaViibryd

European Commission backs wider use of Merck’s Erbitux

European Commission backs wider use of Merck’s Erbitux

24-12-2013

Merck Serono, the biopharmaceutical division of Germany’s Merck KGaA, has gained European Commission…

ErbituxEuropeMerck KGaAMerck SeronoOncologyPharmaceuticalRegulation

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

20-11-2013

Privately-held Biopharma GmbH says it has signed an agreement with Merck Serono, the biopharma subsidiary…

Anti-Arthritics/RheumaticsBiopharm GmbHMerck KGaAMerck SeronoPharmaceuticalResearch

Merck KGaA to invest 80 million euros in China pharma production

Merck KGaA to invest 80 million euros in China pharma production

15-11-2013

Germany’s Merck KGaA said this morning that it plans to invest 80 million euros ($106.8 million) in…

Asia-PacificFinancialMerck KGaAMerck SeronoPharmaceuticalProduction

Merck KGaA improves guidance with strong third quarter results

Merck KGaA improves guidance with strong third quarter results

14-11-2013

Germany’s Merck KGaA (MRK: DE) has posted solid organic revenue growth of 4.7% for the third quarter…

BiotechnologyErbituxEuropeFinancialMerck KGaAMerck SeronoPharmaceuticalRebif

Germany’s Merck reorganizes pharma management team

Germany’s Merck reorganizes pharma management team

27-09-2013

German pharma and chemicals major Merck KGaA yesterday announced multiple management and organizational…

EuropeManagementMerck KGaAMerck SeronoPharmaceutical

ObsEva gets funding and makes deal with Merck Serono

30-08-2013

Geneva, Switzerland-based ObsEva says that it has closed a 32 million Swiss franc ($34.8 million) -A…

FinancialLicensingMerck KGaAMerck SeronoObsEvaPharmaceuticalWomen's Health

Merck KGaA 2nd-qtr sales slip, but EBITDA beats forecasts

06-08-2013

German health care and chemicals firm Merck KGaA (MRK: DE) reported second-quarter 2013 financial results,…

FinancialMerck KGaAMerck SeronoPharmaceutical

Oncologists favor Avastin as first-line therapy for metastatic colorectal cancer

27-06-2013

For the treatment of metastatic colorectal cancer (mCRC), a majority of surveyed US oncologists surveyed…

AvastinBayerBiotechnologyBristol-Myers SquibbErbituxMarkets & MarketingMerck SeronoNorth AmericaOncologyPharmaceuticalRegeneronRocheSanofiStivargaZaltrap

Merck Serono sets up new platform for cancer therapies innovation

26-06-2013

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA (MRK: DE) says it has created a…

BiotechnologyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck Serono collaborates with China's BeiGene on second-generation BRAF Inhibitor

31-05-2013

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), today (May 31) announced that it has signed…

BeiGeneBeiGene-283BiotechnologyLicensingMerck KGaAMerck SeronoOncologyPharmaceutical

Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux

23-05-2013

Australian drug developer Alchemia (ASX: ACL) and Merck Serono, a subsidiary of Germany's Merck KGaA…

AlchemiaBiotechnologyErbituxHA-IrinotecanMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC

16-05-2013

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), announced detailed results from the randomized…

BiotechnologyL-BLP25Merck KGaAMerck SeronoOncologyPharmaceuticalResearchStimuvax

Merck Serono and Quintiles enter novel clinical development partnership

16-05-2013

Merck Serono, the biotech division of Germany's Merck KGaA (MRK: DE) and Quintiles (NYSE: Q) have announced…

BiotechnologyMerck KGaAMerck SeronoPharmaceuticalQuintilesResearch

Merck KGaA adjusted 1st-qtr earnings leap 19%, beating forecasts

14-05-2013

Shares of Germany's Merck KGaA out on 1.9% to 124.52 euros this morning (May 14), after the company reported…

FinancialMerck KGaAMerck SeronoPharmaceutical

AEterna Zentaris transfers Cetrotide rights to Merck KGaA

18-04-2013

Canada's AEterna Zentaris (TSX: AEZ) says that its German subsidiary has entered into binding agreements…

AEterna ZentarisCetrotideLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

Merck Serono's EPP funds EspeRare Foundation, which will reposition rimeporide

15-04-2013

Merck Serono, the biotech unit of Germany's Merck KGaA (MRK: DE) has announced the launch of the EspeRare…

BiotechnologyEspeRare FoundationFinancialMerck KGaAMerck SeronoPharmaceuticalRare diseasesResearchrimeporide

Columbia Labs extends ex-US Crinone accord with Merck Serono into 2020

09-04-2013

USA-based Columbia Laboratories (Nasdaq: CBRX) has amended its license and supply agreement with Merck…

Columbia LaboratoriesCrinoneLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

1 to 25 of 53 results

Back to top